Intel Corporation (INTC) — FY2023 Form 10-K
Business context and reporting period. This annual report covers the fiscal year ended December 30, 2023; it is not a standalone fourth-quarter report. Intel designs, manufactures, and sells semiconductor products and is investing to expand its manufacturing and foundry businesses through its IDM 2.0 strategy. Segment results below reflect the company’s 2023 reporting structure.
Financial performance
| Metric | FY2023 | FY2022 |
|---|---|---|
| Revenue | $54.2B | $63.1B |
| GAAP gross margin | $21.7B; 40.0% | $26.9B; 42.6% |
| Non-GAAP gross margin | 43.6% | 47.3% |
| Operating income | $93M; 0.2% of revenue | $2.3B; 3.7% |
| Net income attributable to Intel | $1.7B | $8.0B |
| Diluted EPS | $0.40 GAAP; $1.05 non-GAAP | $1.94 GAAP; $1.67 non-GAAP |
| Cash from operations | $11.5B | $15.4B |
| Adjusted free cash flow | $(11.9)B | $(4.1)B |
| Capital expenditures | $25.8B | $24.8B |
| Cash and investments | $25.0B | $28.8B |
| Total debt on balance sheet | $49.3B | $42.1B |
| Current assets / current liabilities | $43.3B / $28.1B | $50.4B / $32.2B |
The 2023 income tax benefit was $913M, producing a negative 119.8% effective tax rate; this materially affected the relationship between pretax income and net income. Non-GAAP measures are management-defined and should be considered alongside GAAP results.
Segment results
- Client Computing (CCG): revenue $29.3B, down 8%; operating income $6.5B, up from $5.6B. Lower PC demand and notebook volume weighed on revenue.
- Data Center and AI (DCAI): revenue $15.5B, down 20%; operating loss $530M versus $1.3B operating income. Server volume fell 37% amid a softening CPU data-center market.
- Network and Edge (NEX): revenue $5.8B, down 31%; operating loss $482M versus $1.0B income, as customers reduced inventories and purchases.
- Mobileye: revenue $2.1B, up 11%; operating income $664M, down from $690M.
- Intel Foundry Services (IFS): revenue $952M, up from $469M; operating loss widened to $482M from $281M as spending increased to support growth.
Material changes versus FY2022
- Revenue fell $8.8B, or 14%, reflecting declines in CCG, DCAI, and NEX. GAAP gross margin declined 2.6 percentage points and operating income fell from $2.3B to $93M.
- GAAP diluted EPS fell from $1.94 to $0.40. Non-GAAP diluted EPS fell from $1.67 to $1.05.
- Operating cash flow declined $4.0B. Adjusted free cash flow worsened by $7.8B, primarily as high capital spending continued.
- Cash and investments declined $3.8B while balance-sheet debt increased $7.2B. Intel issued $11.0B of senior notes during 2023.
- Management’s 2023 Q4 revenue included approximately $700M of customer incentives to accelerate purchases and position products; the filing says their effects were contemplated in Q1 2024 guidance.
Outlook, management commentary, risks, and unusual items
- Management said manufacturing investment and capital spending are expected to remain above historical levels for several years, putting pressure on adjusted free cash flow in the near term. It reported $20.4B of capital expenditure commitments for 2024 and $7.1B committed longer term.
- Intel said it believes available funding is sufficient for business requirements over the next 12 months and longer term. It expects to adjust investment timing to roadmap execution and business conditions; the filing provides no clear numerical full-year 2024 revenue or earnings outlook in the supplied text.
- The strategy includes aiming to deliver five process nodes in four years and regain process leadership by 2025, building IFS, and introducing an internal foundry model in 2024. Execution, customer adoption, yields, costs, and returns on substantial manufacturing investments remain uncertain.
- Intel increased the estimated useful life of certain production machinery from five to eight years. Management estimated this reduced 2023 depreciation expense by $4.2B, including an estimated $2.5B increase to gross margin and $400M decrease in R&D expense; actual operating-results effects are not individually quantifiable, according to the filing.
- Legal matters include a $1.0B accrued VLSI litigation charge after reducing a prior $2.2B accrual, and a $401M accrued European Commission fine that Intel appealed. Intel says it cannot reasonably estimate potential VLSI losses above the recorded amount. It also paid Tower Semiconductor a $353M termination fee after the acquisition agreement ended because required regulatory approvals were not obtained in time.
- Key risks include intense competition in CPUs, accelerators, and foundry services; execution and cost risks in the process roadmap and factory expansion; cyclical and uncertain demand; customer concentration; global supply-chain and geopolitical exposure; export controls; cybersecurity and product vulnerabilities; and legal, tax, and regulatory contingencies.
- Three customers represented 40% of 2023 revenue. China accounted for 27% of revenue by customer billing location; $3.2B of revenue depended on US export-control authorizations.
- The auditor issued unqualified opinions on the financial statements and internal control over financial reporting. Inventory valuation was identified as a critical audit matter.
Most important facts for investors to verify
- Whether product demand and customer inventories recover sufficiently to improve CCG, DCAI, and NEX revenue and margins.
- Whether Intel meets process-node and product milestones, achieves competitive yields, and attracts external foundry customers at economically viable returns.
- How depreciation from the $43.4B construction-in-progress balance and future factory capacity utilization affect gross margin and cash flow.
- Whether capital spending, government incentives, partner contributions, and customer commitments align with financing needs; monitor debt, cash and investments, and free cash flow.
- Developments in VLSI and EC proceedings, including possible additional payments or restrictions, and the outcome of the Tower transaction termination.
- Effects of customer incentives, customer concentration, China exposure, and export-control authorizations on reported revenue and future demand.